Comparative, Prospective Study Regarding Efficacy, Safety & Adverse Effects of Anti-Asthmatic Drugs in Case of Mild to Moderate Chronic Stable Persistent Bronchial Asthma in Adults.

Simple item page
dc.contributor.authorMondal, Krishnenduen_US
dc.contributor.authorRupam Kumar T. A.en_US
dc.contributor.authorSen, Pronoyen_US
dc.contributor.authorS., Raghul Rajen_US
dc.date.accessioned2020-11-18T10:18:49Z
dc.date.available2020-11-18T10:18:49Z
dc.date.issued2020-02
dc.description.abstractAsthma is a heterogeneous disease, usually characterized by chronic airway inflammation, bronchoconstriction and airway hyper responsiveness. The addition of an inhaled corticosteroid (ICS) to an inhaled long-acting β2-agonist (LABA) gives optimal control of asthma in most patients. There are few international studies regarding efficacy and safety of LABA/ICS. But in India there is paucity of such studies. Hence the present study was undertaken.METHODSA comparative, prospective, observational study was conducted among 120 patients attending the Out Patient Department of Chest Medicine and Pharmacology of Burdwan Medical College and Hospital, diagnosed as having mild to moderate chronic stable persistent bronchial asthma, receiving combination of LABA and ICS therapy, out of which 16 patients were lost due to follow up, and 104 patients were studied. Patients were divided into 2 groups. Group A received respicaps of combined formoterol 6 μg and budesonide 400 μg DPI, Group B received combined formoterol 6 μg and mometasone 400 μg DPI, twice daily. During exacerbations inhaled salbutamol was utilized as rescue medication. Spirometric parameters, clinical parameters, and adverse effects were recorded on three visits (at 4th, 8th and 12th weeks) and analysed by using different statistical tests.RESULTSComparable clinical improvement of spirometric parameters, Asthma Control Test score of both groups were observed (p-value>0.05). Adverse effects like tremor, pharyngitis, headache, oral candidiasis and dysphonia were recorded among both the groups which was statistically insignificant.CONCLUSIONPatients who received ICS with LABA in both groups experienced a statistically significant improvement in symptoms. Improvement was seen in spirometric parameters as well with a comparable degree of safetyen_US
dc.identifier.affiliationsDepartment of Critical Care Unit, Burdwan Medical College and Hospital, Bardhaman, West Bengal, Indiaen_US
dc.identifier.affiliationsDepartment of Chest Medicine, Burdwan Medical College and Hospital, Bardhaman, West Bengal, India.en_US
dc.identifier.affiliationsDepartment of Chest Medicine, Burdwan Medical College and Hospital, Bardhaman, West Bengal, India.en_US
dc.identifier.affiliationsDepartment of Chest Medicine, Burdwan Medical College and Hospital, Bardhaman, West Bengal, India.en_US
dc.identifier.citationMondal Krishnendu, Rupam Kumar T. A., Sen Pronoy, S. Raghul Raj. Comparative, Prospective Study Regarding Efficacy, Safety & Adverse Effects of Anti-Asthmatic Drugs in Case of Mild to Moderate Chronic Stable Persistent Bronchial Asthma in Adults.. Journal of Evolution of Medical and Dental Sciences. 2020 Feb; 9(6): 347-352en_US
dc.identifier.issn2278-4802
dc.identifier.issn2278-4748
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/215346
dc.languageenen_US
dc.publisherAkshantala Enterprises Private Limiteden_US
dc.relation.issuenumber6en_US
dc.relation.volume9en_US
dc.source.urihttps://dx.doi.org//10.14260/jemds/2020/79en_US
dc.subjectAsthmaen_US
dc.subjectSpirometryen_US
dc.subjectFormoterolen_US
dc.subjectBudesonideen_US
dc.subjectMometasoneen_US
dc.titleComparative, Prospective Study Regarding Efficacy, Safety & Adverse Effects of Anti-Asthmatic Drugs in Case of Mild to Moderate Chronic Stable Persistent Bronchial Asthma in Adults.en_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
jemds2020v9n6p347.pdf
Size:
682.25 KB
Format:
Adobe Portable Document Format
Download
Collections
Journal of Evolution of Medical and Dental Sciences